drug

Glucose clamp technique

MeSH D015309
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
PROCEDURE
Pre-approval / investigational in the US
Developed by Central Institute of Mental Health, Mannheim
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
PROCEDURE

Indications

Trials

1
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NCT01160991—Completed

KOLs & investigators

1
Daniel H. Mathalon, Ph.D., M.D.KOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Central Institute of Mental Health, Mannheim
company
trial
Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose Metabolism
NA
trial
indication
Schizophrenia
indication
Diabetes Mellitus
indication
Diabetes
indication
Schizophrenia
indication
KOL
Daniel H. Mathalon, Ph.D., M.D.
KOL score 5
person